Global Meningococcal Conjugate Market Growth (Status and Outlook) 2022-2028

Publisher Name :
Date: 24-Jan-2022
No. of pages: 102

As the global economy mends, the 2021 growth of Meningococcal Conjugate will have significant change from previous year. According to our (LP Information) latest study, the global Meningococcal Conjugate market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Meningococcal Conjugate market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Meningococcal Conjugate market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Meningococcal Conjugate market, reaching US$ million by the year 2028. As for the Europe Meningococcal Conjugate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Meningococcal Conjugate players cover Sanofi Pasteur, Pfizer, Glaxo Smith Kline, and Hualan Biological Engineering, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Conjugate market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

- Menactra

- Menveo

- NeisVac-C

- Nimenrix

- Others

Segmentation by end user: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

- Children

- Preteens or Teens

- Adults

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

- Sanofi Pasteur

- Pfizer

- Glaxo Smith Kline

- Hualan Biological Engineering

- JN International Medical Corporation

- Baxter International

- Merck

- Serum Institute of India

- Biomed

- Novartis

Global Meningococcal Conjugate Market Growth (Status and Outlook) 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Meningococcal Conjugate Market Size 2017-2028
2.1.2 Meningococcal Conjugate Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Meningococcal Conjugate Segment by Type
2.2.1 Menactra
2.2.2 Menveo
2.2.3 NeisVac-C
2.2.4 Nimenrix
2.2.5 Others
2.3 Meningococcal Conjugate Market Size by Type
2.3.1 Meningococcal Conjugate Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Meningococcal Conjugate Market Size Market Share by Type (2017-2022)
2.4 Meningococcal Conjugate Segment by End User
2.4.1 Children
2.4.2 Preteens or Teens
2.4.3 Adults
2.5 Meningococcal Conjugate Market Size by End User
2.5.1 Meningococcal Conjugate Market Size CAGR by End User (2017 VS 2022 VS 2028)
2.5.2 Global Meningococcal Conjugate Market Size Market Share by End User (2017-2022)
3 Meningococcal Conjugate Market Size by Player
3.1 Meningococcal Conjugate Market Size Market Share by Players
3.1.1 Global Meningococcal Conjugate Revenue by Players (2020-2022)
3.1.2 Global Meningococcal Conjugate Revenue Market Share by Players (2020-2022)
3.2 Global Meningococcal Conjugate Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Meningococcal Conjugate by Regions
4.1 Meningococcal Conjugate Market Size by Regions (2017-2022)
4.2 Americas Meningococcal Conjugate Market Size Growth (2017-2022)
4.3 APAC Meningococcal Conjugate Market Size Growth (2017-2022)
4.4 Europe Meningococcal Conjugate Market Size Growth (2017-2022)
4.5 Middle East & Africa Meningococcal Conjugate Market Size Growth (2017-2022)
5 Americas
5.1 Americas Meningococcal Conjugate Market Size by Country (2017-2022)
5.2 Americas Meningococcal Conjugate Market Size by Type (2017-2022)
5.3 Americas Meningococcal Conjugate Market Size by End User (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meningococcal Conjugate Market Size by Region (2017-2022)
6.2 APAC Meningococcal Conjugate Market Size by Type (2017-2022)
6.3 APAC Meningococcal Conjugate Market Size by End User (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Meningococcal Conjugate by Country (2017-2022)
7.2 Europe Meningococcal Conjugate Market Size by Type (2017-2022)
7.3 Europe Meningococcal Conjugate Market Size by End User (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Meningococcal Conjugate by Region (2017-2022)
8.2 Middle East & Africa Meningococcal Conjugate Market Size by Type (2017-2022)
8.3 Middle East & Africa Meningococcal Conjugate Market Size by End User (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Meningococcal Conjugate Market Forecast
10.1 Global Meningococcal Conjugate Forecast by Regions (2023-2028)
10.1.1 Global Meningococcal Conjugate Forecast by Regions (2023-2028)
10.1.2 Americas Meningococcal Conjugate Forecast
10.1.3 APAC Meningococcal Conjugate Forecast
10.1.4 Europe Meningococcal Conjugate Forecast
10.1.5 Middle East & Africa Meningococcal Conjugate Forecast
10.2 Americas Meningococcal Conjugate Forecast by Country (2023-2028)
10.2.1 United States Meningococcal Conjugate Market Forecast
10.2.2 Canada Meningococcal Conjugate Market Forecast
10.2.3 Mexico Meningococcal Conjugate Market Forecast
10.2.4 Brazil Meningococcal Conjugate Market Forecast
10.3 APAC Meningococcal Conjugate Forecast by Region (2023-2028)
10.3.1 China Meningococcal Conjugate Market Forecast
10.3.2 Japan Meningococcal Conjugate Market Forecast
10.3.3 Korea Meningococcal Conjugate Market Forecast
10.3.4 Southeast Asia Meningococcal Conjugate Market Forecast
10.3.5 India Meningococcal Conjugate Market Forecast
10.3.6 Australia Meningococcal Conjugate Market Forecast
10.4 Europe Meningococcal Conjugate Forecast by Country (2023-2028)
10.4.1 Germany Meningococcal Conjugate Market Forecast
10.4.2 France Meningococcal Conjugate Market Forecast
10.4.3 UK Meningococcal Conjugate Market Forecast
10.4.4 Italy Meningococcal Conjugate Market Forecast
10.4.5 Russia Meningococcal Conjugate Market Forecast
10.5 Middle East & Africa Meningococcal Conjugate Forecast by Region (2023-2028)
10.5.1 Egypt Meningococcal Conjugate Market Forecast
10.5.2 South Africa Meningococcal Conjugate Market Forecast
10.5.3 Israel Meningococcal Conjugate Market Forecast
10.5.4 Turkey Meningococcal Conjugate Market Forecast
10.5.5 GCC Countries Meningococcal Conjugate Market Forecast
10.6 Global Meningococcal Conjugate Forecast by Type (2023-2028)
10.7 Global Meningococcal Conjugate Forecast by End User (2023-2028)

11 Key Players Analysis
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Information
11.1.2 Sanofi Pasteur Meningococcal Conjugate Product Offered
11.1.3 Sanofi Pasteur Meningococcal Conjugate Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Pasteur Main Business Overview
11.1.5 Sanofi Pasteur Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Meningococcal Conjugate Product Offered
11.2.3 Pfizer Meningococcal Conjugate Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Glaxo Smith Kline
11.3.1 Glaxo Smith Kline Company Information
11.3.2 Glaxo Smith Kline Meningococcal Conjugate Product Offered
11.3.3 Glaxo Smith Kline Meningococcal Conjugate Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Glaxo Smith Kline Main Business Overview
11.3.5 Glaxo Smith Kline Latest Developments
11.4 Hualan Biological Engineering
11.4.1 Hualan Biological Engineering Company Information
11.4.2 Hualan Biological Engineering Meningococcal Conjugate Product Offered
11.4.3 Hualan Biological Engineering Meningococcal Conjugate Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Hualan Biological Engineering Main Business Overview
11.4.5 Hualan Biological Engineering Latest Developments
11.5 JN International Medical Corporation
11.5.1 JN International Medical Corporation Company Information
11.5.2 JN International Medical Corporation Meningococcal Conjugate Product Offered
11.5.3 JN International Medical Corporation Meningococcal Conjugate Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 JN International Medical Corporation Main Business Overview
11.5.5 JN International Medical Corporation Latest Developments
11.6 Baxter International
11.6.1 Baxter International Company Information
11.6.2 Baxter International Meningococcal Conjugate Product Offered
11.6.3 Baxter International Meningococcal Conjugate Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Baxter International Main Business Overview
11.6.5 Baxter International Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Meningococcal Conjugate Product Offered
11.7.3 Merck Meningococcal Conjugate Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Information
11.8.2 Serum Institute of India Meningococcal Conjugate Product Offered
11.8.3 Serum Institute of India Meningococcal Conjugate Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Serum Institute of India Main Business Overview
11.8.5 Serum Institute of India Latest Developments
11.9 Biomed
11.9.1 Biomed Company Information
11.9.2 Biomed Meningococcal Conjugate Product Offered
11.9.3 Biomed Meningococcal Conjugate Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Biomed Main Business Overview
11.9.5 Biomed Latest Developments
11.10 Novartis
11.10.1 Novartis Company Information
11.10.2 Novartis Meningococcal Conjugate Product Offered
11.10.3 Novartis Meningococcal Conjugate Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Novartis Main Business Overview
11.10.5 Novartis Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Meningococcal Conjugate Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Menactra
Table 3. Major Players of Menveo
Table 4. Major Players of NeisVac-C
Table 5. Major Players of Nimenrix
Table 6. Major Players of Others
Table 7. Meningococcal Conjugate Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Meningococcal Conjugate Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Meningococcal Conjugate Market Size Market Share by Type (2017-2022)
Table 10. Meningococcal Conjugate Market Size CAGR by End User (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Meningococcal Conjugate Market Size by End User (2017-2022) & ($ Millions)
Table 12. Global Meningococcal Conjugate Market Size Market Share by End User (2017-2022)
Table 13. Global Meningococcal Conjugate Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Meningococcal Conjugate Revenue Market Share by Player (2020-2022)
Table 15. Meningococcal Conjugate Key Players Head office and Products Offered
Table 16. Meningococcal Conjugate Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Meningococcal Conjugate Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Meningococcal Conjugate Market Size Market Share by Regions (2017-2022)
Table 21. Americas Meningococcal Conjugate Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Meningococcal Conjugate Market Size Market Share by Country (2017-2022)
Table 23. Americas Meningococcal Conjugate Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Meningococcal Conjugate Market Size Market Share by Type (2017-2022)
Table 25. Americas Meningococcal Conjugate Market Size by End User (2017-2022) & ($ Millions)
Table 26. Americas Meningococcal Conjugate Market Size Market Share by End User (2017-2022)
Table 27. APAC Meningococcal Conjugate Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Meningococcal Conjugate Market Size Market Share by Region (2017-2022)
Table 29. APAC Meningococcal Conjugate Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Meningococcal Conjugate Market Size Market Share by Type (2017-2022)
Table 31. APAC Meningococcal Conjugate Market Size by End User (2017-2022) & ($ Millions)
Table 32. APAC Meningococcal Conjugate Market Size Market Share by End User (2017-2022)
Table 33. Europe Meningococcal Conjugate Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Meningococcal Conjugate Market Size Market Share by Country (2017-2022)
Table 35. Europe Meningococcal Conjugate Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Meningococcal Conjugate Market Size Market Share by Type (2017-2022)
Table 37. Europe Meningococcal Conjugate Market Size by End User (2017-2022) & ($ Millions)
Table 38. Europe Meningococcal Conjugate Market Size Market Share by End User (2017-2022)
Table 39. Middle East & Africa Meningococcal Conjugate Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Meningococcal Conjugate Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Meningococcal Conjugate Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Meningococcal Conjugate Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Meningococcal Conjugate Market Size by End User (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Meningococcal Conjugate Market Size Market Share by End User (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Meningococcal Conjugate
Table 46. Key Market Challenges & Risks of Meningococcal Conjugate
Table 47. Key Industry Trends of Meningococcal Conjugate
Table 48. Global Meningococcal Conjugate Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Meningococcal Conjugate Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Meningococcal Conjugate Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Meningococcal Conjugate Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Meningococcal Conjugate Market Size Forecast by End User (2023-2028) & ($ Millions)
Table 53. Global Meningococcal Conjugate Market Size Market Share Forecast by End User (2023-2028)
Table 54. Sanofi Pasteur Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors
Table 55. Sanofi Pasteur Meningococcal Conjugate Product Offered
Table 56. Sanofi Pasteur Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Sanofi Pasteur Main Business
Table 58. Sanofi Pasteur Latest Developments
Table 59. Pfizer Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors
Table 60. Pfizer Meningococcal Conjugate Product Offered
Table 61. Pfizer Main Business
Table 62. Pfizer Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Pfizer Latest Developments
Table 64. Glaxo Smith Kline Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors
Table 65. Glaxo Smith Kline Meningococcal Conjugate Product Offered
Table 66. Glaxo Smith Kline Main Business
Table 67. Glaxo Smith Kline Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Glaxo Smith Kline Latest Developments
Table 69. Hualan Biological Engineering Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors
Table 70. Hualan Biological Engineering Meningococcal Conjugate Product Offered
Table 71. Hualan Biological Engineering Main Business
Table 72. Hualan Biological Engineering Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Hualan Biological Engineering Latest Developments
Table 74. JN International Medical Corporation Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors
Table 75. JN International Medical Corporation Meningococcal Conjugate Product Offered
Table 76. JN International Medical Corporation Main Business
Table 77. JN International Medical Corporation Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. JN International Medical Corporation Latest Developments
Table 79. Baxter International Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors
Table 80. Baxter International Meningococcal Conjugate Product Offered
Table 81. Baxter International Main Business
Table 82. Baxter International Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Baxter International Latest Developments
Table 84. Merck Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors
Table 85. Merck Meningococcal Conjugate Product Offered
Table 86. Merck Main Business
Table 87. Merck Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Merck Latest Developments
Table 89. Serum Institute of India Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors
Table 90. Serum Institute of India Meningococcal Conjugate Product Offered
Table 91. Serum Institute of India Main Business
Table 92. Serum Institute of India Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Serum Institute of India Latest Developments
Table 94. Biomed Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors
Table 95. Biomed Meningococcal Conjugate Product Offered
Table 96. Biomed Main Business
Table 97. Biomed Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Biomed Latest Developments
Table 99. Novartis Details, Company Type, Meningococcal Conjugate Area Served and Its Competitors
Table 100. Novartis Meningococcal Conjugate Product Offered
Table 101. Novartis Main Business
Table 102. Novartis Meningococcal Conjugate Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Novartis Latest Developments
List of Figures
Figure 1. Meningococcal Conjugate Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Meningococcal Conjugate Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Meningococcal Conjugate Market Size Market Share by Type in 2021
Figure 7. Meningococcal Conjugate in Children
Figure 8. Global Meningococcal Conjugate Market: Children (2017-2022) & ($ Millions)
Figure 9. Meningococcal Conjugate in Preteens or Teens
Figure 10. Global Meningococcal Conjugate Market: Preteens or Teens (2017-2022) & ($ Millions)
Figure 11. Meningococcal Conjugate in Adults
Figure 12. Global Meningococcal Conjugate Market: Adults (2017-2022) & ($ Millions)
Figure 13. Global Meningococcal Conjugate Market Size Market Share by End User in 2021
Figure 14. Global Meningococcal Conjugate Revenue Market Share by Player in 2021
Figure 15. Global Meningococcal Conjugate Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Meningococcal Conjugate Market Size 2017-2022 ($ Millions)
Figure 17. APAC Meningococcal Conjugate Market Size 2017-2022 ($ Millions)
Figure 18. Europe Meningococcal Conjugate Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Meningococcal Conjugate Market Size 2017-2022 ($ Millions)
Figure 20. Americas Meningococcal Conjugate Value Market Share by Country in 2021
Figure 21. Americas Meningococcal Conjugate Consumption Market Share by Type in 2021
Figure 22. Americas Meningococcal Conjugate Market Size Market Share by End User in 2021
Figure 23. United States Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Meningococcal Conjugate Market Size Market Share by Region in 2021
Figure 28. APAC Meningococcal Conjugate Market Size Market Share by End User in 2021
Figure 29. China Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Meningococcal Conjugate Market Size Market Share by Country in 2021
Figure 36. Europe Meningococcal Conjugate Market Size Market Share by Type in 2021
Figure 37. Europe Meningococcal Conjugate Market Size Market Share by End User in 2021
Figure 38. Germany Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Meningococcal Conjugate Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Meningococcal Conjugate Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Meningococcal Conjugate Market Size Market Share by End User in 2021
Figure 46. Egypt Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Meningococcal Conjugate Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 52. APAC Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 53. Europe Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 55. United States Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 56. Canada Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 59. China Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 60. Japan Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 61. Korea Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 63. India Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 64. Australia Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 65. Germany Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 66. France Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 67. UK Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 68. Italy Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 69. Russia Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 70. Spain Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 73. Israel Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Meningococcal Conjugate Market Size 2023-2028 ($ Millions)
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs